by Long Island Attorney Paul A. Lauto, Esq.
Sexual dysfunction medications have become a multi-billion dollar industry, with multiple drugs available for men and one sexual dysfunction drug now approved by the FDA for women (See our September 8, 2015 article entitled "Three Times Is The Charm For Female Libido Pill"). While many champion these drugs for resurrecting their sex lives, others caution against potential side effects. Case and point is a recent study by Harvard researchers published in the Journal of American Medical Association (JAMA), linking Viagra to melanoma.
The observational study was performed on approximately 26,000 men over a 10 year period of time. The findings reportedly show that men using Viagra have an 84% increased risk of developing melanoma. Notwithstanding, the study did not in itself prove Viagra causes melanoma and does not change clinical recommendations for use of the drug. However, it appears to be more than enough to warrant additional research and investigation. This is especially true in light of the fact that melanoma is one of the more potentially deadly cancers with approximately 76,000 Americans diagnosed per year and 10,000 deaths.
The study did not include other popular sexual dysfunction medications such as Cialis and Levitra, because Viagra was the only such drug approved at the time the study began. At the very least, this information can now be used in a risk/reward analysis between doctor and patient and hopefully afford essential early detection of any melanoma warning signs.
Long Island Lawyer
Paul A. Lauto, Esq.
www.liattorney.com
Sexual dysfunction medications have become a multi-billion dollar industry, with multiple drugs available for men and one sexual dysfunction drug now approved by the FDA for women (See our September 8, 2015 article entitled "Three Times Is The Charm For Female Libido Pill"). While many champion these drugs for resurrecting their sex lives, others caution against potential side effects. Case and point is a recent study by Harvard researchers published in the Journal of American Medical Association (JAMA), linking Viagra to melanoma.
The observational study was performed on approximately 26,000 men over a 10 year period of time. The findings reportedly show that men using Viagra have an 84% increased risk of developing melanoma. Notwithstanding, the study did not in itself prove Viagra causes melanoma and does not change clinical recommendations for use of the drug. However, it appears to be more than enough to warrant additional research and investigation. This is especially true in light of the fact that melanoma is one of the more potentially deadly cancers with approximately 76,000 Americans diagnosed per year and 10,000 deaths.
The study did not include other popular sexual dysfunction medications such as Cialis and Levitra, because Viagra was the only such drug approved at the time the study began. At the very least, this information can now be used in a risk/reward analysis between doctor and patient and hopefully afford essential early detection of any melanoma warning signs.
Long Island Lawyer
Paul A. Lauto, Esq.
www.liattorney.com
RSS Feed
